OrthoPediatrics Reports 3Q18 Revenue of $15.8MM, +27.8% vs. 3Q17

OrthoPediatrics’ significant growth for the quarter was driven by their Trauma and Deformity as well as Scoliosis product lines. The company reported 3Q18 revenue of US $15.8MM, +27.8% vs. 3Q17. Robust U.S. sales drove the 52.4% growth of the spine segment, reflecting an initial return on the company’s investment in consigned instrument sets....

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us